Price
CHART BY
Frequently asked questions
What is Stoke's market capitalization?
The market capitalization of Stoke is $1.08B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Stoke's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Stoke is 23.40. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Stoke?
Stoke's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.845. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Stoke's stock?
Currently, 11 analysts cover Stoke's stock, with a consensus target price of $24.22. Analyst ratings provide insights into the stock's expected performance.
What is Stoke's revenue over the trailing twelve months?
Over the trailing twelve months, Stoke reported a revenue of $199.89M.
What is the EBITDA for Stoke?
Stoke's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $44.64M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Stoke?
Stoke has a free cash flow of $61.15M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Stoke have, and what sector and industry does it belong to?
Stoke employs approximately 128 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Stoke's shares?
The free float of Stoke is 45.92M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.08B
- EPS (TTM)
- $0.845
- Free Float
- 45.92M
- P/E ratio (TTM)
- 23.40
- Revenue (TTM)
- $199.89M
- EBITDA (TTM)
- $44.64M
- Free Cashflow (TTM)
- $61.15M
Pricing
- 1D span
- $19.42$20.00
- 52W span
- $5.35$19.97
Analyst Ratings
The price target is $24.22 and the stock is covered by 11 analysts.
Buy
10
Hold
1
Sell
0
Information
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
- Employees
- 128
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US86150R1077
- Primary Ticker
- STOK
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet